Ronald Park, M.D., MBA

Ronald Park is a physician with extensive experience in multiple biopharma functions, including drug pricing and reimbursement. A McKinsey & Company alumnus and Stanford MD/MBA, Dr. Park spent sixteen years in various leadership roles at Roche and Genentech, before joining Ancestry as EVP of Health and DNA in 2020. In 2021, Ron became CEO of Ambys Medicines. While at Roche/Genentech, Ron co-founded and co-led Roche Personalized Healthcare Center of Excellence, leading the company’s efforts to globally accelerate the use of genomics, real-world data, and digital health for the development and delivery of medicines to patients with serious diseases.